Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-1.42%
+15.38%
-17.88%
Top.GainersTop.Gainers highlighting the top gainers of the day, providing timely updates and insights on the market's highest achievers.
10 Mar 2026$ACXP surged 48% as Acurx Pharmaceuticals announced a new clinical trial for Ibezapolstat targeting recurrent Clostridioides difficile infections. The move into Phase 3 development coupled with strong investor anticipation drove heavy buying, reflecting confidence in the company’s late-stage pipeline and potential market impact.
$MGNX climbed 45% after posting five consecutive days of gains. Momentum traders are drawn to the stock’s consistency, and the rising volume indicates a growing institutional interest that has helped sustain the rally while reinforcing bullish sentiment across biotech growth plays.
$TENX advanced 31% following the release of its full-year 2025 financial results and corporate update. Achieving the randomization target in its LEVEL study has set expectations for topline data later this year, and the slightly better-than-expected GAAP EPS of -$0.38 adds to investor optimism that operational execution is improving.
$INKT jumped 29% after MiNK Therapeutics announced a strategic collaboration with C-Further to advance PRAME-targeted iNKT cell therapy for pediatric cancers. The news fueled pre-market buying and highlighted the potential of a high-impact therapy in a rare pediatric oncology niche, capturing the attention of both biotech specialists and speculative investors.
$VTAK rose 25% as Creatd sold its remaining stake in Fly Flyte to Catheter Precision, securing $12 million in cash and equity. This transaction strengthens Creatd’s balance sheet while positioning VTAK for growth, drawing interest from investors tracking corporate spin-offs and strategic divestitures with tangible near-term value.
Join StocksRunner.com for daily market updates, expert analyses, and actionable insights.
Signup now for FREE and stay ahead of the market curve!
Find out what 5,000+ subscribers already know.
Real-time insights for informed decisions.
Limited slots available, SignUp Now!
Please note that the content above should not be considered as investment advice or marketing. It does not take into account the personal data and requirements of any individual. This content is not a substitute for the reader's own judgment and should not be considered as advice or a recommendation for buying or selling any securities or financial products.
Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future
FIND US ON
Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Real-time stock market updates
Expert stock analysis
Investment strategies
Top stock recommendations
Trading signals and opportunities
Discover what is happening right now and piece together the key data activity before the major news outlets catch on. Stay ahead of the trends
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
